Skip to content

Investigating the effect of Virtual Reality in intrauterine sperm insemination

Investigating the effect of Virtual Reality on perceived hospital anxiety, worry and depression and the rate of pregnancy in women who are candidates for intrauterine sperm insemination

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231013059702N2
Enrollment
114
Registered
2024-02-11
Start date
2024-01-11
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Adjustment disorders (occurrence of worry, anxiety and depression following a special and critical situation in life). Condition 2: Reaction to extreme stress, unspecified (commonly seen in infertility). Condition 3: Dangerously obsessive thoughts or ruminations (which prevents the infertile person from going to the hospital to receive further treatment and can lead to more dangerous results for the person). Adjustment disorders Reaction to severe stress, unspecified Predominantl

Interventions

Intervention 1: Intervention group: People in the intervention group will complete the Pennsylvania anxiety and hospital anxiety and depression questionnaires by Sigmund and Snaith one hour before the

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Consent to participate in the study Not having children at home The first treatment experience with sperm intrauterine insemination Infertility of female origin No physical illness Not having mental disorders and no history of drug use in the mental and psychological field No visual impairments No hearing disorders No movement disorders No addiction to smoking, drugs and alcohol The absence of stressful events in the last 6 months, such as the death of loved ones, accidents, etc

Exclusion criteria

Exclusion criteria: Infertility of male origin A candidate for treating infertility with methods other than intrauterine sperm insemination

Design outcomes

Primary

MeasureTime frame
Worry score in the Pennsylvania Worry Questionnaire. Timepoint: Measuring people's level of concern using a questionnaire one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process into the uterus. Method of measurement: Pennsylvania Anxiety Inventory.;Hospital anxiety and depression score in Zigmond and Snaith hospital anxiety and depression questionnaire. Timepoint: Measuring the level of anxiety and depression of people using a questionnaire one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process into the uterus. Method of measurement: Zigmond and Snaith Hospital Anxiety and Depression Questionnaire.

Secondary

MeasureTime frame
The percentage of people who have a positive or negative pregnancy test result. Timepoint: 14 days after the sperm transfer process into the uterus. Method of measurement: Beta pregnancy blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazaleh Gholami

Oroumia University of Medical Sciences

ghazalehgholamii76@gmail.com+98 44 4553 4222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026